HOOKIPA abandons plan to acquire Poolbeg Pharma; issues Rule 2.8 no-offer statement

HOOKIPA Pharma Inc.

HOOKIPA board decides not to proceed with all-share acquisition of Poolbeg Pharma announced on Jan 2, 2025.
Announcement made under UK Takeover Code Rule 2.8; HOOKIPA reserves right to reverse under certain conditions.
Discussions for combination have ceased; no firm offer was made.
Financial adviser Moelis & Company advised HOOKIPA on the potential deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.